Annexin treats first NEXUS expanded-cohort patient in Germany
Annexin Pharmaceuticals treated the first NEXUS expanded-cohort patient in Germany with anti-VEGF followed by vanexin. The patient completed Day 15 follow-up with no adverse events.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.